SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003096
Filing Date
2021-11-04
Accepted
2021-11-04 16:41:24
Documents
75
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cdak-20210930.htm   iXBRL 10-Q 2761184
2 EX-10.1 cdak-ex10_1.htm EX-10.1 1563368
3 EX-31.1 cdak-ex31_1.htm EX-31.1 19647
4 EX-31.2 cdak-ex31_2.htm EX-31.2 20260
5 EX-32.1 cdak-ex32_1.htm EX-32.1 22604
  Complete submission text file 0000950170-21-003096.txt   12434273

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdak-20210930_pre.xml EX-101.PRE 406374
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdak-20210930_cal.xml EX-101.CAL 61561
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdak-20210930.xsd EX-101.SCH 84210
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdak-20210930_lab.xml EX-101.LAB 588006
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdak-20210930_def.xml EX-101.DEF 231748
11 EXTRACTED XBRL INSTANCE DOCUMENT cdak-20210930_htm.xml XML 2115468
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39615 | Film No.: 211380530
SIC: 2836 Biological Products, (No Diagnostic Substances)